UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Melanoma, a Tumor Based on a Mutant Stem Cell?

Journal of investigative dermatology, 2006-01, Vol.126 (1), p.142-153

2006

Link zum Volltext

Verfügbarkeit prüfen

Mutations of the BRAF gene in human cancer

Nature (London), 2002-06, Vol.417 (6892), p.949-954

2002

Link zum Volltext

Verfügbarkeit prüfen

Dendritic Cells Infected with a Vaccinia Vector Carrying the Human gp100 Gene Simultaneously Present Multiple Specificities and Elicit High-Affinity T Cells Reactive to Multiple Epitopes and Restricted by HLA-A2 and -A3

The Journal of immunology (1950), 2000-04, Vol.164 (8), p.4204-4211

2000

Link zum Volltext

Verfügbarkeit prüfen

Generation of primary tumor-specific cytotoxic T lymphocytes from autologous and human lymphocyte antigen class I-matched allogeneic peripheral blood lymphocytes by B7 gene-modified melanoma cells

Cancer research (Chicago, Ill.), 1997-04, Vol.57 (8), p.1561-1568

1997

Link zum Volltext

Verfügbarkeit prüfen

Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell Lines

Science (American Association for the Advancement of Science), 1994-04, Vol.264 (5159), p.716-719

1994

Link zum Volltext

Verfügbarkeit prüfen

Generation of human autologous melanoma-specific cytotoxic T-cells using HLA-A2-matched allogeneic melanomas

Cancer research (Chicago, Ill.), 1990-02, Vol.50 (3), p.492-498

1990

Link zum Volltext

Verfügbarkeit prüfen

Dual recognition of a human cytotoxic T-cell clone for melanoma antigens

Cancer research (Chicago, Ill.), 1996-05, Vol.56 (10), p.2368-2374

1996

Link zum Volltext

Verfügbarkeit prüfen

Murine dendritic cells transfected with human GP100 elicit both antigen‐specific CD8+ and CD4+ T‐cell responses and are more effective than DNA vaccines at generating anti‐tumor immunity

International journal of cancer, 1999-11, Vol.83 (4), p.532-540

1999

Link zum Volltext

Verfügbarkeit prüfen

MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele

The Journal of immunology (1950), 1991-03, Vol.146 (5), p.1692

1991

Link zum Volltext

Verfügbarkeit prüfen

Melanoma, a tumor based on a mutant stem cell?

Journal of investigative dermatology, 2005, Vol.126 (1), p.142-153

2005

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapeutic Potential of Tumor Antigen-Pulsed and Unpulsed Dendritic Cells Generated from Murine Bone Marrow

Cellular immunology, 1997-07, Vol.179 (1), p.84-95

1997

Link zum Volltext

Verfügbarkeit prüfen

Generation of Melanoma-Specific, Cytotoxic CD4+ T Helper 2 Cells: Requirement of both HLA-DR15 and Fas Antigens on Melanomas for Their Lysis by Th2 Cells

Cellular immunology, 2001-06, Vol.210 (2), p.96-105

2001

Link zum Volltext

Verfügbarkeit prüfen

Effect of Irradiation on Cytokine Production, MHC Antigen Expression, and Vaccine Potential of Interleukin-2 and Interferon-γ Gene-Modified Melanoma Cells

Cellular immunology, 1996-08, Vol.171 (2), p.246-254

1996

Link zum Volltext

Verfügbarkeit prüfen

Recognition and Lysis of Human Melanoma by a CD3+, CD4+, CD8−T-Cell Clone Restricted by HLA-A2

Cellular immunology, 1996-08, Vol.172 (1), p.52-59

1996

Link zum Volltext

Verfügbarkeit prüfen

A phase I trial of human gamma interferon transduced autologous tumor cells in patients with disseminated malignant melanoma

Human gene therapy, 1994, Vol.5 (6), p.761-777

1994

Link zum Volltext

Verfügbarkeit prüfen

Screen and identification of proteins interacting with ADAM19 cytoplasmic tail

Molecular biology reports, 2002-09, Vol.29 (3), p.317-323

2002

Link zum Volltext

Verfügbarkeit prüfen

Human T cells specifically activated against autologous malignant melanoma

Archives of surgery (Chicago. 1960), 1987-12, Vol.122 (12), p.1407

1987

Link zum Volltext

Verfügbarkeit prüfen

Transduction of human melanoma cells with interleukin-2 gene reduces tumorigenicity and enhances host antitumor immunity: a nude mouse model

Cellular immunology, 1994-11, Vol.159 (1), p.26-39

1994

Link zum Volltext

Verfügbarkeit prüfen

Autologous lymph node cell‐derived tumor‐specific cytotoxic t‐cells for use in adoptive immunotherapy of human melanoma

Cancer, 1988-07, Vol.62 (1), p.84-91

1988

Link zum Volltext

Verfügbarkeit prüfen

A Phase I Trial of Human Gamma Interferon Transduced Autologous Tumor Cells in Patients with Disseminated Malignant Melanoma. Duke University Medical Center, Durham, North Carolina

Human gene therapy, 1994-06, Vol.5 (6), p.761-777

1994

Link zum Volltext

Verfügbarkeit prüfen

Human melanoma‐mediated inhibition of autologous CD4+ helper tumor‐infiltrating lymphocyte growth in vitro

Cancer, 1992-04, Vol.69 (7), p.1843-1849

1992

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy of Human Melanoma With Gene-Modified Tumor Cell Vaccines

Cancer control, 1995-10, Vol.2 (5), p.415-423

1995

Link zum Volltext

Verfügbarkeit prüfen

Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapy

Cancer Immunology Immunotherapy, 1993-01, Vol.37 (1), p.15-25

1993

Link zum Volltext

Verfügbarkeit prüfen

Human melanoma-mediated inhibition of autologous CD4+ helper tumor-infiltrating lymphocyte growthin vitro

Cancer, 1992-04, Vol.69 (7), p.1843-1849

1992

Link zum Volltext

Verfügbarkeit prüfen

Combined Hardening of Composite Materials Based on Aluminum

Materials science (New York, N.Y.), 2002-11, Vol.38 (6), p.903

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(42)
Bücher
(1)

Sprache

Englisch
(42)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(29)
Science & Technology
(29)
Life Sciences & Biomedicine
(26)
T-Lymphocytes, Cytotoxic - Immunology
(20)
Melanoma - Immunology
(17)
Biological And Medical Sciences
(15)
Medical Sciences
(14)
Tumor Cells, Cultured
(14)
Animals
(13)
Mice
(11)
Cytotoxicity, Immunologic
(9)
Immunology
(9)
Oncology
(9)
Female
(8)
Tumors
(8)
Immunotherapy
(7)
Male
(7)
Melanoma - Therapy
(7)
Lymphocyte Activation
(6)
Antigens, Neoplasm - Immunology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Melanoma, a Tumor Based on a Mutant Stem Cell?

Mutations of the BRAF gene in human cancer

Dendritic Cells Infected with a Vaccinia Vector Carrying the Human gp100 Gene Simultaneously Present Multiple Specificities and Elicit High-Affinity T Cells Reactive to Multiple Epitopes and Restricted by HLA-A2 and -A3

Generation of primary tumor-specific cytotoxic T lymphocytes from autologous and human lymphocyte antigen class I-matched allogeneic peripheral blood lymphocytes by B7 gene-modified melanoma cells

Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell Lines

Generation of human autologous melanoma-specific cytotoxic T-cells using HLA-A2-matched allogeneic melanomas

Dual recognition of a human cytotoxic T-cell clone for melanoma antigens

Murine dendritic cells transfected with human GP100 elicit both antigen‐specific CD8+ and CD4+ T‐cell responses and are more effective than DNA vaccines at generating anti‐tumor immunity

MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele

Melanoma, a tumor based on a mutant stem cell?

Immunotherapeutic Potential of Tumor Antigen-Pulsed and Unpulsed Dendritic Cells Generated from Murine Bone Marrow

Generation of Melanoma-Specific, Cytotoxic CD4+ T Helper 2 Cells: Requirement of both HLA-DR15 and Fas Antigens on Melanomas for Their Lysis by Th2 Cells

Effect of Irradiation on Cytokine Production, MHC Antigen Expression, and Vaccine Potential of Interleukin-2 and Interferon-γ Gene-Modified Melanoma Cells

Recognition and Lysis of Human Melanoma by a CD3+, CD4+, CD8−T-Cell Clone Restricted by HLA-A2

A phase I trial of human gamma interferon transduced autologous tumor cells in patients with disseminated malignant melanoma

Screen and identification of proteins interacting with ADAM19 cytoplasmic tail

Human T cells specifically activated against autologous malignant melanoma

Transduction of human melanoma cells with interleukin-2 gene reduces tumorigenicity and enhances host antitumor immunity: a nude mouse model

Autologous lymph node cell‐derived tumor‐specific cytotoxic t‐cells for use in adoptive immunotherapy of human melanoma

A Phase I Trial of Human Gamma Interferon Transduced Autologous Tumor Cells in Patients with Disseminated Malignant Melanoma. Duke University Medical Center, Durham, North Carolina

Human melanoma‐mediated inhibition of autologous CD4+ helper tumor‐infiltrating lymphocyte growth in vitro

Immunotherapy of Human Melanoma With Gene-Modified Tumor Cell Vaccines

Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapy

Human melanoma-mediated inhibition of autologous CD4+ helper tumor-infiltrating lymphocyte growthin vitro

Combined Hardening of Composite Materials Based on Aluminum

Suchergebnisse filtern